Effect of Dexmedetomidine on Inflammatory Response in Aortic Dissection

Dexmedetomidine Reduces Inflammation in Aortic Dissection

Authors

  • Lulu Gao Department of Anesthesiology, The Third Affiliated Hospital of Soochow University, Changzhou, China
  • Baihan Jin NO. 971 Hospital of The People's Liberation Army Navy, China
  • Jiang Shen Department of Anesthesiology, The Third Affiliated Hospital of Soochow University, Changzhou, China
  • Xiaoying Zhang Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China

DOI:

https://doi.org/10.1532/hsf.5025

Keywords:

Dexmedetomidine, Aortic dissection, Inflammatory factor

Abstract

Objective: To study the effect of dexmedetomidine (Dex) on perioperative inflammatory response in aortic dissection (AD) patients.

Methods: From June 2020 to June 2022, 50 patients with Stanford type B AD underwent endovascular stent-graft exclusion (EVAR) at our hospital. They randomly were assigned to two groups (N = 25): the control group (C group) and the Dex group. Patients in the Dex group received 0.5ug/kg Dex intravenously 10 minutes before induction of anesthesia and 0.5µg/kg/h Dex during the intervention until 15 minutes before the end of surgery. In contrast, the C group received the same volume of normal saline at the same time points. The two groups were induced and maintained with the same anesthetic agents. Venous blood samples were taken 3 days before operation (T1), 1 day before operation (T2), 1 day after operation (T3) and 3 days after operation (T4) to detect levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell count (WBC).

Results: At T3 and T4, CRP and ESR in the Dex group were significantly improved compared with those in the C group.

Conclusion: Dexmedetomidine can reduce the inflammatory reaction of aortic dissection.

References

Afifi RO, Sandhu HK, Leake SS, Boutrous ML, Kumar V, 3rd, Azizzadeh A, Charlton-Ouw KM, Saqib NU, Nguyen TC, Miller CC, 3rd, et al. 2015. Outcomes of Patients With Acute Type B (DeBakey III) Aortic Dissection: A 13-Year, Single-Center Experience. Circulation. 132(8):748-754.

Anzai A, Shimoda M, Endo J, Kohno T, Katsumata Y, Matsuhashi T, Yamamoto T, Ito K, Yan X, Shirakawa K, et al. 2015. Adventitial CXCL1/G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture. Circulation research. 116(4):612-623.

Fattori R, Cao P, De Rango P, Czerny M, Evangelista A, Nienaber C, Rousseau H, Schepens M. 2013. Interdisciplinary expert consensus document on management of type B aortic dissection. Journal of the American College of Cardiology. 61(16):1661-1678.

Gavazzi G, Deffert C, Trocme C, Schäppi M, Herrmann FR, Krause KH. 2007. NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension (Dallas, Tex: 1979). 50(1):189-196.

Gu J, Sun P, Zhao H, Watts HR, Sanders RD, Terrando N, Xia P, Maze M, Ma D. 2011. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Critical care (London, England). 15(3):R153.

Hofer S, Steppan J, Wagner T, Funke B, Lichtenstern C, Martin E, Graf BM, Bierhaus A, Weigand MA. 2009. Central sympatholytics prolong survival in experimental sepsis. Critical care (London, England). 13(1):R11.

İşcan Ş, Gökalp O, Dönmez K, Lafçı B. 2018. About inflammatory activation during aortic dissection. Anatolian journal of cardiology. 20(5):306.

Ju X, Ijaz T, Sun H, Ray S, Lejeune W, Lee C, Recinos A, 3rd, Guo DC, Milewicz DM, Tilton RG, et al. 2013. Interleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL/6 mice. Arterioscler Thromb Vasc Biol. 33(7):1612-1621.

Klimscha W, Tong C, Eisenach JC. 1997. Intrathecal alpha 2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study. Anesthesiology. 87(1):110-116.

Lai YC, Tsai PS, Huang CJ. 2009. Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages. The Journal of surgical research. 154(2):212-219.

Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W, et al. 2013. Acute kidney injury: an increasing global concern. Lancet (London, England). 382(9887):170-179.

Lankadeva YR, Ma S, Iguchi N, Evans RG, Hood SG, Farmer DGS, Bailey SR, Bellomo R, May CN. 2019. Dexmedetomidine reduces norepinephrine requirements and preserves renal oxygenation and function in ovine septic acute kidney injury. Kidney international. 96(5):1150-1161.

Levey AS, James MT. 2017. Acute Kidney Injury. Annals of internal medicine. 167(9):Itc66-itc80.

Li Y, He R, Chen S, Qu Y. 2015. Effect of dexmedetomidine on early postoperative cognitive dysfunction and peri-operative inflammation in elderly patients undergoing laparoscopic cholecystectomy. Experimental and therapeutic medicine. 10(5):1635-1642.

Liu W, Wang B, Wang T, Liu X, He X, Liu Y, Li Z, Zeng H. 2016. Ursodeoxycholic Acid Attenuates Acute Aortic Dissection Formation in Angiotensin II-Infused Apolipoprotein E-Deficient Mice Associated with Reduced ROS and Increased Nrf2 Levels. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 38(4):1391-1405.

Maes M, Lin A, Kenis G, Egyed B, Bosmans E. 2000. The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products. Psychiatry research. 96(3):245-253.

Miksa M, Das P, Zhou M, Wu R, Dong W, Ji Y, Goyert SM, Ravikumar TS, Wang P. 2009. Pivotal role of the alpha(2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis. PLoS One. 4(5):e5504.

Ohta Y, Miyamoto K, Kawazoe Y, Yamamura H, Morimoto T. 2020. Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: a sub-analysis of a multicenter randomized clinical trial. Critical care (London, England). 24(1):493.

Qiao H, Sanders RD, Ma D, Wu X, Maze M. 2009. Sedation improves early outcome in severely septic Sprague Dawley rats. Critical care (London, England). 13(4):R136.

Shan XS, Dai HR, Zhao D, Yang BW, Feng XM, Liu H, Peng K, Ji FH. 2021. Dexmedetomidine reduces acute kidney injury after endovascular aortic repair of Stanford type B aortic dissection: A randomized, double-blind, placebo-controlled pilot study. Journal of clinical anesthesia. 75:110498.

Si Y, Bao H, Han L, Shi H, Zhang Y, Xu L, Liu C, Wang J, Yang X, Vohra A, et al. 2013. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation. Journal of translational medicine. 11:141.

Son BK, Sawaki D, Tomida S, Fujita D, Aizawa K, Aoki H, Akishita M, Manabe I, Komuro I, Friedman SL, et al. 2015. Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma. Nature communications. 6:6994.

Szelényi J, Kiss JP, Vizi ES. 2000. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. Journal of neuroimmunology. 103(1):34-40.

Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H. 2008. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. Journal of anesthesia. 22(3):221-228.

Wang Q, Chen Z, Peng X, Zheng Z, Le A, Guo J, Ma L, Shi H, Yao K, Zhang S, et al. 2021. Neuraminidase 1 Exacerbating Aortic Dissection by Governing a Pro-Inflammatory Program in Macrophages. Frontiers in cardiovascular medicine. 8:788645.

Wang X, Zhang H, Cao L, He Y, Ma A, Guo W. 2020. The Role of Macrophages in Aortic Dissection. Frontiers in physiology. 11:54.

Yang L, Xing G, Wang L, Wu Y, Li S, Xu G, He Q, Chen J, Chen M, Liu X, et al. 2015. Acute kidney injury in China: a cross-sectional survey. Lancet (London, England). 386(10002):1465-1471.

Yao H, Chi X, Jin Y, Wang Y, Huang P, Wu S, Xia Z, Cai J. 2015. Dexmedetomidine Inhibits TLR4/NF-κB Activation and Reduces Acute Kidney Injury after Orthotopic Autologous Liver Transplantation in Rats. Sci Rep. 5:16849.

Ye J, Wang M, Jiang H, Ji Q, Huang Y, Liu J, Zeng T, Xu Y, Wang Z, Lin Y, et al. 2018. Increased levels of interleukin-22 in thoracic aorta and plasma from patients with acute thoracic aortic dissection. Clin Chim Acta. 486:395-401.

Zamani MM, Keshavarz-Fathi M, Fakhri-Bafghi MS, Hirbod-Mobarakeh A, Rezaei N, Bahrami A, Nader ND. 2016. Survival benefits of dexmedetomidine used for sedating septic patients in intensive care setting: A systematic review. Journal of critical care. 32:93-100.

Zhang P, Hou S, Chen J, Zhang J, Lin F, Ju R, Cheng X, Ma X, Song Y, Zhang Y, et al. 2016. Smad4 Deficiency in Smooth Muscle Cells Initiates the Formation of Aortic Aneurysm. Circulation research. 118(3):388-399.

Zhao S, Wu W, Lin X, Shen M, Yang Z, Yu S, Luo Y. 2022. Protective effects of dexmedetomidine in vital organ injury: crucial roles of autophagy. Cellular & molecular biology letters. 27(1):34.

Zeng T, Shi L, Ji Q, Shi Y, Huang Y, Liu Y, Gan J, Yuan J, Lu Z, Xue Y, et al. 2018. Cytokines in aortic dissection. Clin Chim Acta. 486:177-182.

Published

2022-12-15

How to Cite

Gao, L., Jin, B., Shen, J., & Zhang, X. (2022). Effect of Dexmedetomidine on Inflammatory Response in Aortic Dissection: Dexmedetomidine Reduces Inflammation in Aortic Dissection. The Heart Surgery Forum, 25(6), E829-E832. https://doi.org/10.1532/hsf.5025

Issue

Section

Article